Randi Elin Gislefoss

  • Researcher

Publications 2021

Gislefoss RE, Berge U, Lauritzen M, Langseth H, Wojewodzic MW (2021)
A Simple and Cost-Effective Method for Measuring Hemolysis in Biobank Serum Specimens
Biopreserv Biobank, 19 (6), 525-530
DOI 10.1089/bio.2021.0037, PubMed 34613836

Hektoen HH, Gislefoss RE, Stenehjem JS, Langseth H, Axcrona K, Mondul AM, Robsahm TE, Andreassen BK (2021)
Prediagnostic Serum 25-Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort
Clin Epidemiol, 13, 801-811
DOI 10.2147/CLEP.S319620, PubMed 34548821

Hektoen HH, Robsahm TE, Stenehjem JS, Axcrona K, Babigumira R, Mondul AM, Gislefoss RE, Andreassen BK (2021)
Vitamin D and Vitamin D-binding protein and risk of bladder cancer: A nested case-control study in the Norwegian Janus Serum Bank Cohort
Cancer Med, 10 (12), 4107-4116
DOI 10.1002/cam4.3960, PubMed 34080787

Publications 2020

Guldvik IJ, Zuber V, Braadland PR, Grytli HH, Ramberg H, Lilleby W, Thiede B, Zucknick M, Saatcioglu F, Gislefoss R, Kvåle R, George A, Grönberg H, Wiklund F, Neal DE, Gnanapragasam VJ, Taskén KA, Mills IG (2020)
Identification and Validation of Leucine-rich α-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification
Eur Urol Open Sci, 21, 51-60
DOI 10.1016/j.euros.2020.08.007, PubMed 34337468

Hektoen HH, Robsahm TE, Andreassen BK, Stenehjem JS, Axcrona K, Mondul A, Gislefoss RE (2020)
Lifestyle associated factors and risk of urinary bladder cancer: A prospective cohort study from Norway
Cancer Med, 9 (12), 4420-4432
DOI 10.1002/cam4.3060, PubMed 32319230

Keller A, Fehlmann T, Backes C, Kern F, Gislefoss R, Langseth H, Rounge TB, Ludwig N, Meese E (2020)
Competitive learning suggests circulating miRNA profiles for cancers decades prior to diagnosis
RNA Biol, 17 (10), 1416-1426
DOI 10.1080/15476286.2020.1771945, PubMed 32456538

Xie SH, Ness-Jensen E, Langseth H, Gislefoss RE, Mattsson F, Lagergren J (2020)
Prediagnostic circulating levels of sex hormones and survival in esophageal adenocarcinoma
Int J Cancer, 148 (4), 905-913
DOI 10.1002/ijc.33285, PubMed 32895915

Xie SH, Ness-Jensen E, Rabbani S, Langseth H, Gislefoss RE, Mattsson F, Lagergren J (2020)
Circulating Sex Hormone Levels and Risk of Esophageal Adenocarcinoma in a Prospective Study in Men
Am J Gastroenterol, 115 (2), 216-223
DOI 10.14309/ajg.0000000000000446, PubMed 31658123

Publications 2019

Rounge TB, Lauritzen M, Erlandsen SE, Langseth H, Holmen OL, Gislefoss RE (2019)
Ultralow amounts of DNA from long-term archived serum samples produce quality genotypes
Eur J Hum Genet, 28 (4), 521-524
DOI 10.1038/s41431-019-0543-x, PubMed 31719661

Publications 2018

Bollineni RC, Koehler CJ, Gislefoss RE, Anonsen JH, Thiede B (2018)
Large-scale intact glycopeptide identification by Mascot database search
Sci Rep, 8 (1), 2117
DOI 10.1038/s41598-018-20331-2, PubMed 29391424

Bollineni RC, Koehler CJ, Gislefoss RE, Anonsen JH, Thiede B (2018)
Author Correction: Large-scale intact glycopeptide identification by Mascot database search
Sci Rep, 8 (1), 9771
DOI 10.1038/s41598-018-28147-w, PubMed 29934554

Gislefoss RE, Stenehjem JS, Hektoen HH, Andreassen BK, Langseth H, Axcrona K, Weiderpass E, Mondul A, Robsahm TE (2018)
Vitamin D, obesity and leptin in relation to bladder cancer incidence and survival: prospective protocol study
BMJ Open, 8 (3), e019309
DOI 10.1136/bmjopen-2017-019309, PubMed 29602840

Perez-Cornago A, Appleby PN, Boeing H, Gil L, Kyrø C, Ricceri F, Murphy N, Trichopoulou A, Tsilidis KK, Khaw KT, Luben RN, Gislefoss RE, Langseth H, Drake I, Sonestedt E, Wallström P, Stattin P, Johansson A, Landberg R, Nilsson LM, Ozasa K, Tamakoshi A, Mikami K, Kubo T, Sawada N et al. (2018)
Circulating isoflavone and lignan concentrations and prostate cancer risk: a meta-analysis of individual participant data from seven prospective studies including 2,828 cases and 5,593 controls
Int J Cancer, 143 (11), 2677-2686
DOI 10.1002/ijc.31640, PubMed 29971774

Travis RC, Perez-Cornago A, Appleby PN, Albanes D, Joshu CE, Lutsey PL, Mondul AM, Platz EA, Weinstein SJ, Layne TM, Helzlsouer KJ, Visvanathan K, Palli D, Peeters PH, Bueno-de-Mesquita B, Trichopoulou A, Gunter MJ, Tsilidis KK, Sánchez MJ, Olsen A, Brenner H, Schöttker B, Perna L, Holleczek B, Knekt P et al. (2018)
A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk
Cancer Res, 79 (1), 274-285
DOI 10.1158/0008-5472.CAN-18-2318, PubMed 30425058

Watts EL, Appleby PN, Perez-Cornago A, Bueno-de-Mesquita HB, Chan JM, Chen C, Cohn BA, Cook MB, Flicker L, Freedman ND, Giles GG, Giovannucci E, Gislefoss RE, Hankey GJ, Kaaks R, Knekt P, Kolonel LN, Kubo T, Le Marchand L, Luben RN, Luostarinen T, Männistö S, Metter EJ, Mikami K, Milne RL et al. (2018)
Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies
Eur Urol, 74 (5), 585-594
DOI 10.1016/j.eururo.2018.07.024, PubMed 30077399

Publications 2017

Gislefoss RE, Lauritzen M, Langseth H, Mørkrid L (2017)
Effect of multiple freeze-thaw cycles on selected biochemical serum components
Clin Chem Lab Med, 55 (7), 967-973
DOI 10.1515/cclm-2016-0892, PubMed 27987362

Hjerkind KV, Gislefoss RE, Tretli S, Nystad W, Bjørge T, Engeland A, Meyer HE, Holvik K, Ursin G, Langseth H (2017)
Cohort Profile Update: The Janus Serum Bank Cohort in Norway
Int J Epidemiol, 46 (4), 1101-1102f
DOI 10.1093/ije/dyw302, PubMed 28087783

Keller A, Rounge T, Backes C, Ludwig N, Gislefoss R, Leidinger P, Langseth H, Meese E (2017)
Sources to variability in circulating human miRNA signatures
RNA Biol, 14 (12), 1791-1798
DOI 10.1080/15476286.2017.1367888, PubMed 28820329

Langseth H, Gislefoss RE, Martinsen JI, Dillner J, Ursin G (2017)
Cohort Profile: The Janus Serum Bank Cohort in Norway
Int J Epidemiol, 46 (2), 403-404g
DOI 10.1093/ije/dyw027, PubMed 27063606

Publications 2016

Andreassen BK, Aagnes B, Gislefoss R, Andreassen M, Wahlqvist R (2016)
Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014
BMC Cancer, 16 (1), 799
DOI 10.1186/s12885-016-2832-x, PubMed 27737647

Faust H, Andersson K, Luostarinen T, Gislefoss RE, Dillner J (2016)
Cutaneous Human Papillomaviruses and Squamous Cell Carcinoma of the Skin: Nested Case-Control Study
Cancer Epidemiol Biomarkers Prev, 25 (4), 721-4
DOI 10.1158/1055-9965.EPI-15-1290, PubMed 26908428

Lumme S, Tenkanen L, Langseth H, Gislefoss R, Hakama M, Stattin P, Hallmans G, Adlercreutz H, Saikku P, Stenman UH, Tuohimaa P, Luostarinen T, Dillner J (2016)
Longitudinal biobanks-based study on the joint effects of infections, nutrition and hormones on risk of prostate cancer
Acta Oncol, 55 (7), 839-45
DOI 10.3109/0284186X.2016.1139178, PubMed 26878091

Price AJ, Travis RC, Appleby PN, Albanes D, Barricarte Gurrea A, Bjørge T, Bueno-de-Mesquita HB, Chen C, Donovan J, Gislefoss R, Goodman G, Gunter M, Hamdy FC, Johansson M, King IB, Kühn T, Männistö S, Martin RM, Meyer K, Neal DE, Neuhouser ML, Nygård O, Stattin P, Tell GS, Trichopoulou A et al. (2016)
Circulating Folate and Vitamin B12 and Risk of Prostate Cancer: A Collaborative Analysis of Individual Participant Data from Six Cohorts Including 6875 Cases and 8104 Controls
Eur Urol, 70 (6), 941-951
DOI 10.1016/j.eururo.2016.03.029, PubMed 27061263

Publications 2015

Gislefoss RE, Langseth H, Bolstad N, Nustad K, Mørkrid L (2015)
HE4 as an Early Detection Biomarker of Epithelial Ovarian Cancer: Investigations in Prediagnostic Specimens From the Janus Serumbank
Int J Gynecol Cancer, 25 (9), 1608-15
DOI 10.1097/IGC.0000000000000532, PubMed 26501436

Rounge TB, Lauritzen M, Langseth H, Enerly E, Lyle R, Gislefoss RE (2015)
microRNA Biomarker Discovery and High-Throughput DNA Sequencing Are Possible Using Long-term Archived Serum Samples
Cancer Epidemiol Biomarkers Prev, 24 (9), 1381-7
DOI 10.1158/1055-9965.EPI-15-0289, PubMed 26108462

Publications 2014

Gislefoss RE, Grimsrud TK, Mørkrid L (2014)
Stability of selected serum hormones and lipids after long-term storage in the Janus Serum Bank
Clin Biochem, 48 (6), 364-9
DOI 10.1016/j.clinbiochem.2014.12.006, PubMed 25523301

Publications 2013

Andersson K, Luostarinen T, Strand AS, Langseth H, Gislefoss RE, Forslund O, Pawlita M, Waterboer T, Dillner J (2013)
Prospective study of genital human papillomaviruses and nonmelanoma skin cancer
Int J Cancer, 133 (8), 1840-5
DOI 10.1002/ijc.28188, PubMed 23553409

Publications 2012

Andersson K, Michael KM, Luostarinen T, Waterboer T, Gislefoss R, Hakulinen T, Forslund O, Pawlita M, Dillner J (2012)
Prospective study of human papillomavirus seropositivity and risk of nonmelanoma skin cancer
Am J Epidemiol, 175 (7), 685-95
DOI 10.1093/aje/kwr373, PubMed 22419740

Gislefoss RE, Grimsrud TK, Høie K, Mørkrid L (2012)
Stability of testosterone measured in male archival serum samples by two different methods
Scand J Clin Lab Invest, 72 (7), 555-62
DOI 10.3109/00365513.2012.705888, PubMed 22935045

Publications 2011

Hustad S, Eussen S, Midttun Ø, Ulvik A, van de Kant PM, Mørkrid L, Gislefoss R, Ueland PM (2011)
Kinetic modeling of storage effects on biomarkers related to B vitamin status and one-carbon metabolism
Clin Chem, 58 (2), 402-10
DOI 10.1373/clinchem.2011.174490, PubMed 22194632

Keller A, Leidinger P, Gislefoss R, Haugen A, Langseth H, Staehler P, Lenhof HP, Meese E (2011)
Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis
RNA Biol, 8 (3), 506-16
DOI 10.4161/rna.8.3.14994, PubMed 21558792

Publications 2010

Cox B, Richardson A, Graham P, Gislefoss RE, Jellum E, Rollag H (2010)
Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study
Br J Cancer, 102 (11), 1665-9
DOI 10.1038/sj.bjc.6605675, PubMed 20407437

Gislefoss RE (2010)
Quality aspects of long-term stored samples: studies in the Janus Serum Bank of Norway
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 970, 1 b. (flere pag.)
BIBSYS 101339895, ISBN 978-82-8072-502-8

Hannisdal R, Gislefoss RE, Grimsrud TK, Hustad S, Mørkrid L, Ueland PM (2010)
Analytical recovery of folate and its degradation products in human serum stored at -25 degrees C for up to 29 years
J Nutr, 140 (3), 522-6
DOI 10.3945/jn.109.116418, PubMed 20071651

Publications 2009

Gislefoss RE, Grimsrud TK, Mørkrid L (2009)
Stability of selected serum proteins after long-term storage in the Janus Serum Bank
Clin Chem Lab Med, 47 (5), 596-603
DOI 10.1515/CCLM.2009.121, PubMed 19290843

Publications 2008

Gislefoss RE, Grimsrud TK, Mørkrid L (2008)
Long-term stability of serum components in the Janus Serum Bank
Scand J Clin Lab Invest, 68 (5), 402-9
DOI 10.1080/00365510701809235, PubMed 18752145

Publications 2007

Jørgensen KT, Wiik A, Pedersen M, Hedegaard CJ, Vestergaard BF, Gislefoss RE, Kvien TK, Wohlfahrt J, Bendtzen K, Frisch M (2007)
Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors
Ann Rheum Dis, 67 (6), 860-6
DOI 10.1136/ard.2007.073825, PubMed 17644543

Lundstig A, Stattin P, Persson K, Sasnauskas K, Viscidi RP, Gislefoss RE, Dillner J (2007)
No excess risk for colorectal cancer among subjects seropositive for the JC polyomavirus
Int J Cancer, 121 (5), 1098-102
DOI 10.1002/ijc.22770, PubMed 17471560

Pukkala E, Andersen A, Berglund G, Gislefoss R, Gudnason V, Hallmans G, Jellum E, Jousilahti P, Knekt P, Koskela P, Kyyrönen PP, Lenner P, Luostarinen T, Löve A, Ogmundsdóttir H, Stattin P, Tenkanen L, Tryggvadóttir L, Virtamo J, Wadell G, Widell A, Lehtinen M, Dillner J (2007)
Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers
Acta Oncol, 46 (3), 286-307
DOI 10.1080/02841860701203545, PubMed 17450464

Publications 2006

Boffetta P, Clark S, Shen M, Gislefoss R, Peto R, Andersen A (2006)
Serum cotinine level as predictor of lung cancer risk
Cancer Epidemiol Biomarkers Prev, 15 (6), 1184-8
DOI 10.1158/1055-9965.EPI-06-0032, PubMed 16775179

Publications 2005

Anttila T, Tenkanen L, Lumme S, Leinonen M, Gislefoss RE, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Stattin P, Saikku P, Dillner J, Lehtinen M, Hakama M (2005)
Chlamydial antibodies and risk of prostate cancer
Cancer Epidemiol Biomarkers Prev, 14 (2), 385-9
DOI 10.1158/1055-9965.EPI-03-0325, PubMed 15734962

Tedeschi R, Luostarinen T, De Paoli P, Gislefoss RE, Tenkanen L, Virtamo J, Koskela P, Hallmans G, Lehtinen M, Dillner J (2005)
Joint Nordic prospective study on human herpesvirus 8 and multiple myeloma risk
Br J Cancer, 93 (7), 834-7
DOI 10.1038/sj.bjc.6602751, PubMed 16136049

Publications 2004

Bjørge T, Lie AK, Hovig E, Gislefoss RE, Hansen S, Jellum E, Langseth H, Nustad K, Tropé CG, Dørum A (2004)
BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study
Br J Cancer, 91 (10), 1829-34
DOI 10.1038/sj.bjc.6602199, PubMed 15477862

Ekstrøm PO, Bjørge T, Dørum A, Longva AS, Heintz KM, Warren DJ, Hansen S, Gislefoss RE, Hovig E (2004)
Determination of hereditary mutations in the BRCA1 gene using archived serum samples and capillary electrophoresis
Anal Chem, 76 (15), 4406-9
DOI 10.1021/ac049788k, PubMed 15283579

Ulvik A, Vollset SE, Hansen S, Gislefoss R, Jellum E, Ueland PM (2004)
Colorectal cancer and the methylenetetrahydrofolate reductase 677C -> T and methionine synthase 2756A -> G polymorphisms: a study of 2,168 case-control pairs from the JANUS cohort
Cancer Epidemiol Biomarkers Prev, 13 (12), 2175-80
PubMed 15598777

Publications 2003

Stattin P, Kaaks R, Johansson R, Gislefoss R, Söderberg S, Alfthan H, Stenman UH, Jellum E, Olsson T (2003)
Plasma leptin is not associated with prostate cancer risk
Cancer Epidemiol Biomarkers Prev, 12 (5), 474-5
PubMed 12750247

Publications 2002

Bjørge T, Engeland A, Luostarinen T, Mork J, Gislefoss RE, Jellum E, Koskela P, Lehtinen M, Pukkala E, Thoresen SØ, Dillner J (2002)
Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study
Br J Cancer, 87 (1), 61-4
DOI 10.1038/sj.bjc.6600350, PubMed 12085257

Publications 1999

Elgstoen KBP, Gislefoss R, Jellum E (1999)
Recent advances in the clinical applications of capillary electrophoresis
Chromatographia, 49 1, S79-S80

Publications 1998

Engvig JP, Olsen KE, Gislefoss RE, Sletten K, Wahlström O, Westermark P (1998)
Constant region of a kappa III immunoglobulin light chain as a major AL-amyloid protein
Scand J Immunol, 48 (1), 92-8
DOI 10.1046/j.1365-3083.1998.00352.x, PubMed 9714416

Publications 1997

Dillner J, Lehtinen M, Björge T, Luostarinen T, Youngman L, Jellum E, Koskela P, Gislefoss RE, Hallmans G, Paavonen J, Sapp M, Schiller JT, Hakulinen T, Thoresen S, Hakama M (1997)
Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer
J Natl Cancer Inst, 89 (17), 1293-9
DOI 10.1093/jnci/89.17.1293, PubMed 9293920

Jellum E, Dollekamp H, Brunsvig A, Gislefoss R (1997)
Diagnostic applications of chromatography and capillary electrophoresis
J Chromatogr B Biomed Sci Appl, 689 (1), 155-64
DOI 10.1016/s0378-4347(96)00333-7, PubMed 9061490

Publications 1995

Gislefoss RE (1995)
Karakterisering av et Bence Jones protein fra en pasient med myelomaassosiert amyloidose
[R.E. Gislefoss>, Oslo, 120 s.
BIBSYS 950495344

Page visits: 6200